Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-04-30 to 2024-05-01
Current total value of award: $7330.5
Description: 4564448755!FASENRA 30 MG/ML SYRINGEML